RSS
Pseudomonas aeruginosa (P. aeruginosa)
Biotech receives Innovate UK funding to support development of intravenous antibiotic project
Biotechnology company, Phico Therapeutics, has been awarded significant funding from Innovate UK to support the manufacturing development of its intravenous antibiotic, SASPject PT3.8. Read more
Visterra awarded R&D contract to advance new candidate
Clinical-stage biotechnology company, Visterra, has been awarded a research and development contract from the public-private partnership, Combating Antibiotic Resistant Bacteria Accelerator (CARB-X). Read more
Cepheid, MedImmune and Combacte team up against pneumonia
Cepheid is collaborating with Combacte and MedImmune, to identify pneumonia bacteria in patients so they can be entered into clinical programmes Read more
